NextCure, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold NXTC, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
6
Funds holding
$143050
Total value held
Buying
3 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Pfizer Inc | $72967 | 44347 | -113299 | -71.87% |
| 2 | Blackrock, Inc. | $59757 | 37348 | +9555 | +34.38% |
| 3 | Barclays Plc | $9162 | 5726 | +100 | +1.78% |
| 4 | Ubs Group Ag | $951 | 594 | +594 | NEW BUY |
| 5 | Jpmorgan Chase & Co | $107 | 61 | — | Held |
| 6 | Morgan Stanley | $106 | 66 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.